GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » Cyclically Adjusted PB Ratio

WIN-Partners Co (TSE:3183) Cyclically Adjusted PB Ratio : 1.84 (As of Jun. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co Cyclically Adjusted PB Ratio?

As of today (2024-06-10), WIN-Partners Co's current share price is 円1195.00. WIN-Partners Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was 円648.12. WIN-Partners Co's Cyclically Adjusted PB Ratio for today is 1.84.

The historical rank and industry rank for WIN-Partners Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:3183' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.81   Med: 1.72   Max: 2.15
Current: 1.84

During the past years, WIN-Partners Co's highest Cyclically Adjusted PB Ratio was 2.15. The lowest was 0.81. And the median was 1.72.

TSE:3183's Cyclically Adjusted PB Ratio is ranked worse than
58.46% of 65 companies
in the Medical Distribution industry
Industry Median: 1.35 vs TSE:3183: 1.84

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

WIN-Partners Co's adjusted book value per share data for the three months ended in Dec. 2023 was 円795.084. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円648.12 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


WIN-Partners Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for WIN-Partners Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co Cyclically Adjusted PB Ratio Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.93 1.91 1.71

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 1.71 1.68 1.72 1.85

Competitive Comparison of WIN-Partners Co's Cyclically Adjusted PB Ratio

For the Medical Distribution subindustry, WIN-Partners Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's Cyclically Adjusted PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Cyclically Adjusted PB Ratio falls into.



WIN-Partners Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

WIN-Partners Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1195.00/648.12
=1.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WIN-Partners Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, WIN-Partners Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=795.084/106.8000*106.8000
=795.084

Current CPI (Dec. 2023) = 106.8000.

WIN-Partners Co Quarterly Data

Book Value per Share CPI Adj_Book
201112 284.369 94.300 322.064
201203 297.438 95.100 334.031
201206 290.465 94.400 328.619
201209 299.477 94.400 338.815
201212 311.133 94.100 353.124
201303 324.520 94.200 367.927
201309 307.471 95.400 344.213
201512 0.000 98.100 0.000
201603 485.155 97.900 529.260
201606 0.000 98.100 0.000
201609 0.000 98.000 0.000
201612 517.847 98.400 562.053
201703 539.690 98.100 587.552
201706 532.346 98.500 577.204
201709 549.203 98.800 593.673
201712 593.448 99.400 637.628
201803 618.788 99.200 666.195
201806 603.224 99.200 649.439
201809 621.011 99.900 663.904
201812 654.212 99.700 700.801
201903 680.886 99.700 729.374
201906 666.995 99.800 713.778
201909 685.408 100.100 731.284
201912 701.094 100.500 745.043
202003 714.275 100.300 760.564
202006 688.476 99.900 736.028
202009 701.944 99.900 750.427
202012 716.630 99.300 770.756
202103 736.317 99.900 787.174
202106 714.995 99.500 767.452
202109 730.507 100.100 779.402
202112 753.339 100.100 803.762
202203 764.326 101.100 807.419
202206 743.577 101.800 780.098
202209 755.281 103.100 782.386
202212 784.050 104.100 804.386
202303 801.644 104.400 820.073
202306 761.808 105.200 773.394
202309 781.704 106.200 786.120
202312 795.084 106.800 795.084

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


WIN-Partners Co  (TSE:3183) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


WIN-Partners Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines